Literature DB >> 7846693

Isolation and characterization of Textarin, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom.

K Stocker1, H Hauer, C Müller, D A Triplett.   

Abstract

The venom of P. textilis contains two different enzymes which convert human prothrombin into thrombin. Prothrombin activation by Textarin, a serine proteinase containing a calcium-binding molecule site, with a molecular mass of 50,000 to 53,000 Da and I.P. 5.5, separated from crude venom by either barium citrate adsorption or hydroxyl apatite chromatography, is strongly stimulated by phospholipid and calcium ions. A second activator, found in the supernatant of barium citrate adsorbed venom solution, activates prothrombin in the absence of any co-factor. Human plasma coagulation induced by Textarin, phospholipid and calcium ions is affected by lupus anticoagulants. Textarin may thus be used for the detection of lupus anticoagulants in patient plasma samples.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846693     DOI: 10.1016/0041-0101(94)90352-2

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Whole blood thrombin: development of a process for intra-operative production of human thrombin.

Authors:  Vijay Kumar; John R Chapman
Journal:  J Extra Corpor Technol       Date:  2007-03

2.  Autologous thrombin: intraoperative production from whole blood.

Authors:  Vijay Kumar; John R Chapman
Journal:  J Extra Corpor Technol       Date:  2008-06

3.  Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device.

Authors:  Vijay Kumar; Trista Madsen; Haihong Zhu; Elisabeth Semple
Journal:  J Extra Corpor Technol       Date:  2005-12

Review 4.  Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.

Authors:  Julien Slagboom; Jeroen Kool; Robert A Harrison; Nicholas R Casewell
Journal:  Br J Haematol       Date:  2017-02-24       Impact factor: 6.998

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.